Polarean Imaging Plc Market Cap ($11.75K)
Market Cap & Net Worth: Polarean Imaging Plc (POLX)
Polarean Imaging Plc market cap. Polarean Imaging Plc (LSE:POLX) has a market capitalization of $11.75K (GBX96.56 Million) as of November 8, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31859 globally and #1291 in its home market, demonstrating a -48.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Polarean Imaging Plc's stock price GBX0.08 by its total outstanding shares 1207032781 (1.21 Billion). Also see POLX cash flow metrics for how efficiently the company converts equity into cash flow.
Polarean Imaging Plc Market Cap History (2018–2025)
Polarean Imaging Plc market cap history from 2018 to 2025. Data shows change from $2.28 Million to $11.75K (-49.57% CAGR). Check POLX stock price for real-time trading data and today's change.
Index Memberships
Polarean Imaging Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$990.01 Million | 0.00% | #467 of 722 |
Weight: Polarean Imaging Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Polarean Imaging Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Polarean Imaging Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Polarean Imaging Plc (POLX) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.08x
Polarean Imaging Plc's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $2.28 Million | $2.44 Million | -$5.64 Million | 0.93x | N/A |
| 2019 | $3.23 Million | $2.30 Million | -$6.10 Million | 1.40x | N/A |
| 2020 | $9.99 Million | $1.06 Million | -$6.55 Million | 9.45x | N/A |
| 2021 | $8.30 Million | $1.19 Million | -$14.02 Million | 7.00x | N/A |
| 2022 | $8.22 Million | $1.03 Million | -$13.91 Million | 7.96x | N/A |
| 2023 | $917.88K | $890.93K | -$11.88 Million | 1.03x | N/A |
| 2024 | $194.59K | $2.42 Million | -$6.68 Million | 0.08x | N/A |
Competitor Companies of POLX by Market Capitalization
Companies near Polarean Imaging Plc in the global market cap rankings as of November 8, 2026. Also see POLX total assets for a full breakdown of the balance sheet.
Key companies related to Polarean Imaging Plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Polarean Imaging Plc (2018–2025)
Market capitalization of Polarean Imaging Plc from 2018 to today. Between 2018 and today, Polarean Imaging Plc's market cap moved from $2.28 Million to $ 11.75K, with a yearly change of -49.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | GBX11.75K | -93.96% |
| 2024 | GBX194.59K | -78.80% |
| 2023 | GBX917.88K | -88.84% |
| 2022 | GBX8.22 Million | -0.88% |
| 2021 | GBX8.30 Million | -16.91% |
| 2020 | GBX9.99 Million | +209.09% |
| 2019 | GBX3.23 Million | +41.94% |
| 2018 | GBX2.28 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Polarean Imaging Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.75K USD |
| MoneyControl | $11.75K USD |
| MarketWatch | $11.75K USD |
| marketcap.company | $11.75K USD |
| Reuters | $11.75K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Polarean Imaging Plc
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more